GABA in the female brain - Oestrous cycle-related changes in GABAergic function in the periaqueductal grey matter

Pharmacology Biochemistry and Behavior

Volumn 90, Issue 1, 2008, Pages 43-50

  Lovick, T A ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Allopregnanolone; GABAA receptor subunit plasticity; Oestrous cycle; Panic; Periaqueductal grey matter; Premenstrual syndrome; Progesterone; Rat

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; CHOLECYSTOKININ B RECEPTOR; PROGESTERONE; RECEPTOR SUBUNIT;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BRAIN; DIESTRUS; DRUG MECHANISM; ENVIRONMENTAL FACTOR; ESTRUS CYCLE; FEMALE; HORMONE ACTION; IMMUNOCOMPETENT CELL; MALE; NERVE CELL; NONHUMAN; PANIC; PERIAQUEDUCTAL GRAY MATTER; PLASTICITY; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN CHEMISTRY; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENT; ESTROUS CYCLE; FEMALE; GAMMA-AMINOBUTYRIC ACID; GONADAL STEROID HORMONES; IMMUNOHISTOCHEMISTRY; MALE; PERIAQUEDUCTAL GRAY; PREGNANOLONE; PROGESTERONE; RATS; RATS, WISTAR; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, GABA-A; SEX CHARACTERISTICS; STEROIDS;

ANIMALIA; RATTUS; RODENTIA;

EID: 44649104569     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2007.12.014     Document Type: Article

References (40)

1. Bäckström T., Andreen L., Birzniece V., Björn I., Johansson I.M., Nordenstram-Haghjo M., et al. The role of hormones and hormonal treatments in premenstrual syndrome. CNS Drugs 17 (2003) 325
2. Bertoglio L.J., and Zangrossi Jr. H. Involvement of dorsolateral periaqueductal gray cholecystokinin-2 receptors in the regulation of a panic-related behavior in rats. Brain Res 1059 (2005) 46-51
3. Brack K.E., and Lovick T.A. Neuronal excitability in the periaqueductal grey matter during the oestrous cycle in female Wistar rats. Neuroscience 144 (2007) 325-335
4. Brack K.E., Jeffery S.M.T., and Lovick T.A. Cardiovascular and respiratory responses to a panicognic agent in anaesthetised female Wistar rats at different stages of the oestrous cycle. Eur J Neurosci 23 (2006) 3309-3318
5. Ensom. MHH Gender based differences and menstrual cycle-related changes in specific diseases: implications for pharmacotherapy. Pharmacotherapy 20 (2000) 523-539
6. Falkenstein E., Tillmann H.C., Christ M., Furing M., and Wehling M. Multiple actions of steroid hormones - a focus on rapid nongenomic effects. Pharmacol Rev 52 (2000) 513-555
7. Fillingim R.B., and Ness T.J. Sex-related hormonal influences on pain and analgesic responses. Neurosci Biobehav Rev 24 (2000) 485-501
8. A receptor subunits in the periaqueductal grey matter in female rats. J Comp Neurol 486 (2005) 89-97
9. A receptor subunits: plasticity of expression during the oestrous cycle. Neuroscience 136 (2005) 457-466
10. A receptors. NeuroReport 14 (2003) 43-46
11. A receptor in the amygdala after progesterone withdrawal. Eur J Neurosci 17 (2003) 641-648
12. Halbreich U. The etiology, biology, and evolving pathology of premenstrual syndromes. Psychoneuroendocrinology 28 Suppl 3 (2003) 55-99
13. Hart S.A., Patton J.D., and Woolley C.S. Quantitative analysis of ER alpha and GAD colocalization in the hippocampus of the adult female rat. J Comp Neurol 440 (2001) 144-155
14. A receptors by endogenous and synthetic neuroactive steroids. Brain Res Rev 37 (2001) 68-80
15. Li X., and Han J.S. Cholecystokinin-octapeptide antagonizes morphine analgesia in periaqueductal gray of the rat. Brain Res 480 (1989) 105-110
16. Lovick T.A. Midbrain and medullary regulation of defensive cardiovascular functions. Prog Brain Res 107 (1996) 301-313
17. Lovick T.A., and Stezhka V.V. Neurones in the dorsolateral periaqueductal grey matter in coronal slices of midbrain: electrophysiological and morphological characteristics. Exp Brain Res 124 (1999) 53-58
18. A receptor subunit during the oestrous cycle in rats. Neuroscience 131 (2005) 397-405
19. McLaughlin R.I., Robertson D.M., Healy D.L., Burger H.G., and de Kretser D.M. Circulating immunoreactive inhibin levels during the normal human menstrual cycle. J Clin Endocrinol Metab 65 (1987) 954-961
20. Mody I. Distinguishing between tonic and phasic conductances. Neurochem Res 26 (2001) 907-913
21. A receptor-mediated inhibition. J Physiol 56 (2005) 237-246
22. Netto C.F., and Guimaraes F.S. Anxiogenic effect of cholecystokinin in the dorsal periaqueductal gray. Neuropsychopharmacology 29 (2004) 101-107
23. Orser B.A., Canning K.J., and Macdonald J.F. Mechanisms of general anesthesia. Curr Opin Anaesthesiol 15 (2002) 427-433
24. Paul S.M., and Purdy R.H. Neuroactive steroids. FASEB J 6 (2004) 2311-2322
25. Revel L., Mennuni L., Garafalo P., and Makovec F. CR2945: a novel CCKB receptor antagonist with anxiolytic-like activity. Behav Pharmacol 9 (1998) 183-194
26. Riley III J.L., Robinson M.E., Wise E.A., and Price D.D. A meta-analytic review of pain perception across the menstrual cycle. Pain 81 (1999) 225-235
27. Rudick C.N., and Woolley C.S. Estrogen regulates functional inhibition of hippocampal CA1 pyramidal cells in the adult female rat. J Neurosci 21 (2001) 6532-6543
28. Schenberg L.C., DeAguiar C., and Graeff F.G. GABA modulation of the defence reaction induced by brain electrical stimulation. Physiol Behav 31 (1983) 429-443
29. Schmidt P.J., Purdy R.H., Moore P.H., Paul S.M., and Rubinow D.R. Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects. J Clin Endocrinol Metab 79 (1994) 1256-1260
30. A receptor function in rat brain. J Neurochem 75 (2000) 732-740
31. Serra M, Pisu MG, Mostallino MC, Sanna E, Biggio G. Changes in neuroactive steroid content during social isolation stress modulate GABAA receptor plasticity and function. Brain Res Rev in press. doi:10.1016/j.brainresrev.2007.06.029.
32. A receptor α4 subunit expression prevents withdrawal properties of an endogenous steroid. Nature 382 (1998) 926-930
33. A-gated current and increases the GABAA receptor α4 subunit in association with increased anxiety. J Neurosci 18 (1998) 5275-5284
34. Steiner M. Premenstrual syndromes. Annu Rev Med 48 (1997) 447-455
35. Stezhka V.V., and Lovick T.A. Inhibitory and excitatory projections from the dorsal raphe nucleus to neurons in the dorsolateral periaqueductal gray matter in slices of midbrain maintained in vitro. Neuroscience 62 (1994) 177-187
36. VanderHorst V.G.J.M., Gustafsson J.A., and Ulfhake B. Estrogen receptor-α and -β immunoreactive neurons in the brainstem and spinal cord of male and female mice: relationships to monoaminergic, cholinergic, and spinal projection systems. J Comp Neurol 488 (2005) 152-179
37. van Megan H.J., Westenberg H.G., den Boer J.A., Haigh J.R., and Traub M. Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients. Psychopharmacology 114 (1994) 449-455
38. Walker P., and Carrive P. Role of ventrolateral periaqueductal gray neurons in the behavioral and cardiovascular responses to contextual conditioned fear and poststress recovery. Neuroscience 116 (2003) 897-912
39. Watanabe G., Taya K., and Sasamoto S. Dynamics of ovarian inhibin secretion during the oestrous cycle of the rat. J Endocrinol 126 (1990) 151-157
40. Zanoveli J.M., Netto C.F., Guimaraes F.S., and Zangrossi Jr. H. Systemic and intra-dorsal periaqueductal gray injections of cholecystokinin sulfated octapeptide (CCK-8s) induce a panic-like response in rats submitted to the elevated T-maze. Peptides 25 (2004) 1935-1941